Philips and Quibim Partner to Bring AI-Powered Prostate Cancer Detection to MR Imaging
-
Philips teams with Quibim to provide AI-enabled prostate cancer detection and analysis on MR images, aiming to improve efficiency and personalized treatment.
-
Solution combines Philips' high-speed MR imaging and Quibim's automated prostate segmentation software to enhance diagnostic confidence.
-
Aims to mitigate staff shortages, reduce unnecessary biopsies, and provide better-targeted prostate cancer therapy.
-
Quibim's software helps automate real-time prostate gland segmentation and generate quantitative insights from MR images.
-
Collaboration to be extended to address other forms of cancer beyond prostate cancer in the future.